Menu Search
Equities

SpartanNash Co

SPTN:NSQ

SpartanNash Co

Actions
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (USD)18.58
  • Today's Change0.41 / 2.26%
  • Shares traded206.98k
  • 1 Year change-15.81%
  • Beta0.3760
Data delayed at least 15 minutes, as of Nov 21 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Dec-23
  • 19-Sep-24
  • 17-Oct-24
  • 14-Nov-24
Select bar for recommendation details.
Recommendations14-Nov-24
Buy1
Outperform0
Hold4
Sell0
Strong Sell0

Share price forecast in USD

The 3 analysts offering 12 month price targets for SpartanNash Co have a median target of 21.00, with a high estimate of 26.00 and a low estimate of 20.00. The median estimate represents a 13.02% increase from the last price of 18.58.
High39.9%26.00
Med13.0%21.00
Low7.6%20.00

Dividends in USD

In 2023, SpartanNash Co reported a dividend of 0.86 USD, which represents a 2.38% increase over last year. The 3 analysts covering the company expect dividends of 0.49 USD for the upcoming fiscal year, a decrease of 43.02%.
Div growth (TTM)2.38%
More ▼

Earnings history & estimates in USD

On Nov 07, 2024, SpartanNash Co reported 3rd quarter 2024 earnings of 0.48 per share. This result was in line with the consensus of the 4 analysts following the company and under-performed last year's 3rd quarter results by 11.11%.
The next earnings announcement is expected on Feb 13, 2025.
Average growth rate+2.23%
SpartanNash Co reported annual 2023 earnings of 2.18 per share on Feb 15, 2024.
Average growth rate+31.95%
More ▼

Revenue history & estimates in USD

SpartanNash Company had 3rd quarter 2024 revenues of 2.25bn. This bettered the 2.24bn consensus of the 4 analysts covering the company. This was 22.59% below the prior year's 3rd quarter results.
Average growth rate+1.13%
SpartanNash Company had revenues for the full year 2023 of 9.73bn. This was 0.89% above the prior year's results.
Average growth rate+3.48%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.